Analytical biochemistry · 2025
Oxford Nanopore third generation sequencing for analysis of FMR1 5'UTR CGG repeat expansions.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yang Xu, Han Bowei, Huang Jie, Zhang Min, Weng Shi, Ouyang Guojun, Han Wanqing, Wang Wenyu, Zhang Li, Chen Juanjuan, Du Juan, Wu Yingsong, Yang Xuexi
Аннотация
OBJECTIVE: Fragile X syndrome is mainly caused by the expansion of GC-rich cytosine-guanine-guanine (CGG) repeat in FMR1 5'UTR region, as well as rare gene point mutations or deletions in its open reading frame. Currently, third-generation long-read sequencing is a potential technology for simultaneously detecting CGG repeat expansions, point mutations, and deletions. However, a major challenge remains in obtaining the target long-fragment CGG repeat region with ultra-high GC content for sequencing.
METHODS: We developed a novel approach combining long-fragment ultra-high GC polymerase chain reaction (PCR) amplification with Oxford Nanopore sequencing to detect the full spectrum of FMR1 5'UTR CGG repeat mutations. The method was validated using 10 standard cell line samples (males: nnormal = 1, nintermediate = 1, npre-mutation = 1, and nfull mutation = 2; females: nnormal = 1, nintermediate = 1, npre-mutation = 2, and nfull mutation = 1) and 53 retrospective clinical blood samples (males: nnormal = 7, npre-mutation = 3, nfull mutation = 15, and nmosaicmutaion = 2; females: nnormal = 9, npre-mutation = 13, and nfull mutation = 4).
RESULTS: Our method demonstrated that the 100 % concordance with the triplet repeat-primed PCR and Southern blot analysis in genotyping 10 cell line samples and 53 clinical samples. Additionally, CGG repeat numbers showed strong correlation with reference mehods (male cell lines, n = 5, R2 = 0.9996; female cell lines, n = 5, R2 = 0.9972; clinical male samples, n = 26, R2 = 1.0000; clinical female samples, n = 25, R2 = 0.9854).
CONCLUSION: This study presents a simple and cost-effective strategy for preparing FMR1 5'UTR CGG repeat regions with long-fragment ultra-high GC content for third-generation sequencing. The approach could serve as a model for detecting other challenging disorders caused by short tandem repeat expansions, such as myotonic dystrophy and Huntington' s disease.
METHODS: We developed a novel approach combining long-fragment ultra-high GC polymerase chain reaction (PCR) amplification with Oxford Nanopore sequencing to detect the full spectrum of FMR1 5'UTR CGG repeat mutations. The method was validated using 10 standard cell line samples (males: nnormal = 1, nintermediate = 1, npre-mutation = 1, and nfull mutation = 2; females: nnormal = 1, nintermediate = 1, npre-mutation = 2, and nfull mutation = 1) and 53 retrospective clinical blood samples (males: nnormal = 7, npre-mutation = 3, nfull mutation = 15, and nmosaicmutaion = 2; females: nnormal = 9, npre-mutation = 13, and nfull mutation = 4).
RESULTS: Our method demonstrated that the 100 % concordance with the triplet repeat-primed PCR and Southern blot analysis in genotyping 10 cell line samples and 53 clinical samples. Additionally, CGG repeat numbers showed strong correlation with reference mehods (male cell lines, n = 5, R2 = 0.9996; female cell lines, n = 5, R2 = 0.9972; clinical male samples, n = 26, R2 = 1.0000; clinical female samples, n = 25, R2 = 0.9854).
CONCLUSION: This study presents a simple and cost-effective strategy for preparing FMR1 5'UTR CGG repeat regions with long-fragment ultra-high GC content for third-generation sequencing. The approach could serve as a model for detecting other challenging disorders caused by short tandem repeat expansions, such as myotonic dystrophy and Huntington' s disease.